In order to investigate the effect of polymers on release mechanism of poorly soluble drugs from solid dispersions, Clonazepam was used as a model drug for these purposes. Five types of solid dispersions were prepared using polyethylene glycol 6000 (PEG-6000), Kollicoat IR, Kollidon VA 64 and Poloxomer in different drug-tocarrier ratios (1:2, 1:4, 1:6, 1:8, 1:10). The solvent evaporation method was used for preparation of solid dispersions. The in-vitro dissolution study with temperature of 37° C and a paddle method, 100 rpm was used in 1000 ml of distilled water as dissolution medium in each dissolution basket for the pure drug and solid dispersions. For pure Clonazepam showed very slow dissolution rate and the solid dispersion considerably enhanced the dissolution rate. Decreased crystalline and increased amorphous fraction of the drug was probably done by wettability and dispersibility. The highest improvement in wettability and dissolution rate of Clonazepam was observed in PEG-6000, Poloxomer and Kollidon VA 64 (1:10 ratio). 
. Improvement of aqueous solubility in such a case is a valuable goal to improve therapeutic efficacy.
Several attempts have been reported in literature using solid dispersion technique to increase the dissolution characteristics where Hydroxy Propyl methyl cellulose (HPMC), polyvinylpyrrolidone (PVP), polyethylene glycol, sodium carboxymethyl cellulose, sodium starch glycolate, pregelatinized starch were used as solubilizing agents [12] [13] [14] .
In this study, solid dispersions were formulated with three water soluble polymers by solvent evaporation technique. Micronized poloxamer 407, Kollicoat IR and Kollidon VA 64 were utilized for this purpose. Poloxamers are nonionic polyoxyethylene-polyoxypropylene copolymers used primarily as emulsifiers, solubilizing agents, wetting agents and have been reported for enhancing the solubility and bioavailability of sparingly soluble drugs in solid dosage forms [15] [16] [17] . Solid dispersions were prepared with poloxamer by melting method for rofecoxib and ibuprofen 18 . Reduced crystalline structure and improved wettability 19, 20 were mentioned as the mechanism by which poloxamer can enhance dissolution from solid dispersions. Solid dispersions formulations of gliclazide can be successfully used to design a solid dosage form of the drug, which would have significant advantages over the current marketed 
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The objective of the present study was to improve the solubility of Clonazepam by using three different types of water soluble polymers. The formulations were characterized by in vitro dissolution study to compare the effects of polymers on the preparation of solid dispersion and dissolution enhancement.
Materials and methods

Materials:
Clonazepam was a gift sample from Rangs Pharmaceuticals Ltd., Dhaka, Bangladesh. Poloxamer 407 (Lutrol 127), Kollicoat IR and Kollidon VA 64 was gifted by BASF, PEG 6000 (Loba Chemie, India), reagent grade methanol (Merck, Germany) were purchased from the market.
Preparation of solid dispersions
Solid dispersion with different polymer showed in the table 1-3. 50 mg of clonazepam was taken in the vial and 4ml acetone was added in each. The drug was completely dissolved in the solvent. Then different types of polymer were added in the solution and sonicated it for 1 min. All solutions were dried by hot air. When the solutions were evaporated completely, they were stored in a dessicator. The formulations were withdrawn from vials, crushed by morter and pestle, passed through 36 micron sieves. Finally lactose was added in the formulation. Then formulations were transferred in vials and stored in a dessicator. A slightly different approach was warranted for solid dispersions containing poloxamer as it is low melting substance (melting temp. 52-57 o C) and melting method was most suitable for this polymer 18, 19 .
The drug was dispersed with methanol in a glass flask and heated in a water bath at 50 o C. Poloxamer was added to the dispersion and it was melted at that temperature.
The solvent was evaporated during constant mixing and the resulting solid mass was Preparation of standard curve of clonazepam in distilled water 
Quantitative assay
Formulation containing clonazepam was taken in a morter and triturated properly until fine powder was formed. 5 mg equivalent of fine powder was taken in a 10 ml volumetric flask with the help of a funnel. 5 ml methanol and 5 ml distil water was added with the powder, sonicated in a sonicator to make a clear solution and then finally was filtered. From this solution 2 ml drug solution was withdrawn and taken in 8 a 100 ml volumetric fiask. The volume of drug solution was then adjusted up to 100 ml with distil water. In the same way, 10 mg equivalent of fine powder was taken in a 25 ml volumetric flask with the help of a funnel. 10 ml methanol and 15 ml distil water was added with the powder, sonicated in a sonicator to make a clear solution and then finally was filtered. From this solution 2 ml drug solution was withdrawn and taken in a 100 ml volumetric fiask. The volume of drug solution was then adjusted up to 100 ml with distil water. For reagent blank 1 ml methanol was transferred into a 100 ml volumetric flask, diluted to 100 ml with distil water. Absorbance value was determined using UV-spectrophotometer (UV-mini-1240, SHIMADZU CORP., Kyoto, Japan), at 254 nm. Solutions were also diluted if necessary. Using the absorbence value, the amount of clonazepam entrapped was determined with the help of standard curve. 
